Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lingman Ma, Xuanyi Li, Zhaoshi Bai, Xinhao Lin & Kejiang Lin. (2019) AdipoRs- a potential therapeutic target for fibrotic disorders. Expert Opinion on Therapeutic Targets 23:2, pages 93-106.
Read now
Read now
Articles from other publishers (18)
Nazi Song, Hongjiao Xu, Shuohan Wu, Suijia Luo, Jingyao Xu, Qian Zhao, Rui Wang & Xianxing Jiang. (2023) Synergistic activation of AMPK by AdipoR1/2 agonist and inhibitor of EDPs–EBP interaction recover NAFLD through enhancing mitochondrial function in mice. Acta Pharmaceutica Sinica B 13:2, pages 542-558.
Crossref
Crossref
Nitesh Mani Tripathi & Anupam Bandyopadhyay. (2022) High throughput virtual screening (HTVS) of peptide library: Technological advancement in ligand discovery. European Journal of Medicinal Chemistry 243, pages 114766.
Crossref
Crossref
Rawan Nehme, Mona Diab-Assaf, Caroline Decombat, Laetitia Delort & Florence Caldefie-Chezet. (2022) Targeting Adiponectin in Breast Cancer. Biomedicines 10:11, pages 2958.
Crossref
Crossref
Yuna Lee, Akihiro Nakano, Yuki Nagasato, Takashi Ichinose & Toshiro Matsui. (2022)
In Vitro
and
in Silico
Analyses of the Adiponectin Receptor Agonistic Action of Soybean Tripeptides
. Journal of Agricultural and Food Chemistry 70:25, pages 7695-7703.
Crossref
Crossref
Abhipree Sharma, Michael Mah, Rebecca H. Ritchie & Miles J. De Blasio. (2022) The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?. Pharmacology & Therapeutics 232, pages 108008.
Crossref
Crossref
Jungyoon Ohn, Kyung Wook Been, Jin Yong Kim, Eun Ju Kim, Taeyong Park, Hye‐Jin Yoon, Jeong Seok Ji, Miki Okada‐Iwabu, Masato Iwabu, Toshimasa Yamauchi, Yeon Kyung Kim, Chaok Seok, Ohsang Kwon, Kyu Han Kim, Hyung Ho Lee & Jin Ho Chung. (2021) Discovery of a transdermally deliverable pentapeptide for activating AdipoR1 to promote hair growth. EMBO Molecular Medicine 13:10.
Crossref
Crossref
Simone C. da Silva Rosa, Meilian Liu & Gary Sweeney. (2021) Adiponectin Synthesis, Secretion and Extravasation from Circulation to Interstitial Space. Physiology 36:3, pages 134-149.
Crossref
Crossref
Wenying Shan, Xuanyi Li, Hequan Yao & Kejiang Lin. (2021) Convolutional Neural Network-based Virtual Screening. Current Medicinal Chemistry 28:10, pages 2033-2047.
Crossref
Crossref
Hongjiao Xu, Qian Zhao, Nazi Song, Zhibin Yan, Runfeng Lin, Shuohan Wu, Lili Jiang, Sihua Hong, Junqiu Xie, Huihao Zhou, Rui Wang & Xianxing Jiang. (2020) AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis. Nature Communications 11:1.
Crossref
Crossref
Cleverson D.T. de Freitas, Beatriz C. Nishi, Camila T.M. do Nascimento, Maria Z.R. Silva, Eduardo H.S. Bezerra, Bruno A.M. Rocha, Thalles B. Grangeiro, João P.B. de Oliveira, Pedro F. Noronha Souza & Márcio V. Ramos. (2020) Characterization of Three Osmotin-Like Proteins from Plumeria rubra and Prospection for Adiponectin Peptidomimetics. Protein & Peptide Letters 27:7, pages 593-603.
Crossref
Crossref
Michel Abou-Samra, Camille M. Selvais, Nicolas Dubuisson & Sonia M. Brichard. (2020) Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?. International Journal of Molecular Sciences 21:7, pages 2620.
Crossref
Crossref
Ying Liu, Vivian Vu & Gary Sweeney. (2019) Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases. Frontiers in Endocrinology 10.
Crossref
Crossref
Li Gao, Dingyuan Jiang, Jing Geng, Run Dong & Huaping Dai. (2019) Hydrogen inhalation attenuated bleomycin‐induced pulmonary fibrosis by inhibiting transforming growth factor‐β1 and relevant oxidative stress and epithelial‐to‐mesenchymal transition. Experimental Physiology 104:12, pages 1942-1951.
Crossref
Crossref
Mario Thevis, Katja Walpurgis, Andreas Thomas & Hans Geyer. (2019) Peptidic drugs and drug candidates in sports drug testing: agents affecting mitochondrial biogenesis or preventing activin receptor II activation. Current Opinion in Endocrine and Metabolic Research 9, pages 22-27.
Crossref
Crossref
Laszlo OtvosJr.Jr.. (2019) Potential Adiponectin Receptor Response Modifier Therapeutics. Frontiers in Endocrinology 10.
Crossref
Crossref
Karthikka Palanisamy, Rajiv Raman, Konerirajapuram Natarajan Sulochana & Subbulakshmi Chidambaram. (2019) Adiponectin: A potential candidate for treating fibrosis in posterior segment of the eye. Medical Hypotheses 123, pages 9-12.
Crossref
Crossref
Xiao-Hua Yu, Da-Wei Zhang, Xi-Long Zheng & Chao-Ke Tang. (2018) C1q tumor necrosis factor-related protein 9 in atherosclerosis: Mechanistic insights and therapeutic potential. Atherosclerosis 276, pages 109-116.
Crossref
Crossref
Sunghwan Kim, Younho Lee, Jun Woo Kim, Young-Jin Son, Min Jung Ma, Jee-Hyun Um, Nam Doo Kim, Sang Hyun Min, Dong Il Kim & Brian B. Kim. (2018) Discovery of a novel potent peptide agonist to adiponectin receptor 1. PLOS ONE 13:6, pages e0199256.
Crossref
Crossref